国际口腔医学杂志 ›› 2018, Vol. 45 ›› Issue (1): 36-41.doi: 10.7518/gjkq.2018.01.007
张梅华1, 胡颖2, 孙正3
Zhang Meihua1, Hu Ying2, Sun Zheng3
摘要:
多发性内分泌腺瘤病2型(MEN2)是罕见的常染色体显性遗传病,分为3个亚型:MEN2A、MEN2B及家族性甲状腺髓样癌。主要临床表现是甲状腺髓样癌、嗜铬细胞瘤、甲状旁腺功能亢进、先天性巨结肠及骨骼面部发育异常、口腔黏膜多发性神经纤维瘤等。其中MEN2B患者甲状腺髓样癌发病早、转移率高,并因特殊面容及多发性口腔黏膜神经瘤常首诊于口腔科。MEN2为10号染色体上RET原癌基因突变所导致。目前研究认为,基因型与甲状腺髓样癌发生时间和恶性程度相关,临床可根据基因型制定手术时间及计划。MEN2不同基因突变型引起了RET基本活性的转变,进而引起细胞内外信号通路的变化。本文对MEN2的临床表现、分子学基础、RET基因结构与功能的改变机制及MEN2的诊断与治疗等方面进行综述。
中图分类号:
[1]Thakker RV. Multiple endocrine neoplasia type 1 (MEN1)[J]. Best Pract Res Clin Endocrinol Metab, 2010, 24(3):355-370. [2]Thakker RV. Multiple endocrine neoplasia—synd-romes of the twentieth century[J]. J Clin Endocrinol Metab, 1998, 83(8):2617-2620. [3]Trump D, Farren B, Wooding C, et al. Clinical stu-dies of multiple endocrine neoplasia type 1 (MEN1) [J]. QJM, 1996, 89(9):653-669. [4]Thakker RV. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)[J]. Mol Cell Endocrinol, 2014, 386(1/2):2-15. [5]Moline J, Eng C. Multiple endocrine neoplasia type 2: an overview[J]. Genet Med, 2011, 13(9):755-764. [6]Krampitz GW, Norton JA. RET gene mutations (ge-notype and phenotype) of multiple endocrine neo-plasia type 2 and familial medullary thyroid car-cinoma[J]. Cancer, 2014, 120(13):1920-1931. [7]Kloos RT, Eng C, Evans DB, et al. Medullary thy-roid cancer: management guidelines of the American Thyroid Association[J]. Thyroid, 2009, 19(6):565- 612. [8]Abraham DT, Low TH, Messina M, et al. Medullary thyroid carcinoma: long-term outcomes of surgical treatment[J]. Ann Surg Oncol, 2011, 18(1):219-225. [9]Diaz RE, Wohllk N. Multiple endocrine neoplasia: the Chilean experience[J]. Clinics (Sao Paulo), 2012, 67(Suppl 1):7-11. [10]Brauckhoff M, Machens A, Hess S, et al. Premoni-tory symptoms preceding metastatic medullary thy-roid cancer in MEN 2B: an exploratory analysis[J]. Surgery, 2008, 144(6):1044-1053. [11]Wohllk N, Schweizer H, Erlic Z, et al. Multiple en-docrine neoplasia type 2[J]. Best Pract Res Clin En-docrinol Metab, 2010, 24(3):371-387. [12]Jasim S, Ying AK, Waguespack SG, et al. Multiple endocrine neoplasia type 2B with a RET proto-onco-gene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation[J]. Thyroid, 2011, 21(2):189- 192. [13]Raue F. German medullary thyroid carcinoma/mu-ltiple endocrine neoplasia registry. German MTC/MEN study group. Medullary thyroid carcinoma/multiple endocrine neoplasia type 2[J]. Langenbecks Arch Surg, 1998, 383(5):334-336. [14]Roman S, Lin R, Sosa JA. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pa-thologic predictors of survival in 1252 cases[J]. Can-cer, 2006, 107(9):2134-2142. [15]Casanova S, Rosenberg-Bourgin M, Farkas D, et al. Phaeochromocytoma in multiple endocrine neoplasia type 2A: survey of 100 cases[J]. Clin Endocrinol (Oxf), 1993, 38(5):531-537. [16]Modigliani E, Vasen HM, Raue K, et al. Pheochro-mocytoma in multiple endocrine neoplasia type 2: European study. The Euromen study group[J]. J Intern Med, 1995, 238(4):363-367. [17]Prys-Roberts C. Phaeochromocytoma—recent pro-gress in its management[J]. Br J Anaesth, 2000, 85 (1):44-57. [18]Martucciello G, Lerone M, Bricco L, et al. Multiple endocrine neoplasias type 2B and RET proto-onco-gene[J]. Ital J Pediatr, 2012, 38:9. [19]Camacho CP, Hoff AO, Lindsey SC, et al. Early diagnosis of multiple endocrine neoplasia type 2B: a challenge for physicians[J]. Arq Bras Endocrinol Metabol, 2008, 52(8):1393-1398. [20]Morrison PJ, Nevin NC. Multiple endocrine neo-plasia type 2B (mucosal neuroma syndrome, Wagen-mann-Froboese syndrome)[J]. J Med Genet, 1996, 33(9):779-782. [21]Sallai A, Hosszú E, Gergics P, et al. Orolabial signs are important clues for diagnosis of the rare endo-crine syndrome MEN 2B. Presentation of two unre-lated cases[J]. Eur J Pediatr, 2008, 167(4):441-446. [22]Wray CJ, Rich TA, Waguespack SG, et al. Failure to recognize multiple endocrine neoplasia 2B: more common than we think[J]. Ann Surg Oncol, 2008, 15(1):293-301. [23]Lee NC, Norton JA. Multiple endocrine neoplasia type 2B—genetic basis and clinical expression[J]. Surg Oncol, 2000, 9(3):111-118. [24]Lee MJ, Chung KH, Park JS, et al. Multiple endocrine neoplasia type 2B: early diagnosis by multiple mu-cosal neuroma and its DNA analysis[J]. Ann Dermatol, 2010, 22(4):452-455. [25]Raue F, Frank-Raue K. Update multiple endocrine neoplasia type 2[J]. Fam Cancer, 2010, 9(3):449- 457. [26]Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2[J]. J Clin Endocrinol Metab, 2001, 86(12):5658- 5671. [27]Engiz O, Ocal G, Siklar Z, et al. Early prophylactic thyroidectomy for RET mutation-positive MEN 2B [J]. Pediatr Int, 2009, 51(4):590-593. [28]Collins JM, Chaudhry SI, Gill DS, et al. Multiple endocrine neoplasia in an orthodontic patient: in-terprofessional diagnostic and treatment implications [J]. J Am Dent Assoc, 2012, 143(10):1093-1098. [29]Burzynski GM, Nolte IM, Bronda A, et al. Identi-fying candidate Hirschsprung disease-associated RET variants[J]. Am J Hum Genet, 2005, 76(5):850- 858. [30]Sotos JG. Abraham Lincoln’s marfanoid mother: the earliest known case of multiple endocrine neoplasia type 2B[J]. Clin Dysmorphol, 2012, 21(3):131-136. [31]Aung PP, Ballester LY, Abdullaev Z, et al. ER/PR positive epidermotropic primary cutaneous eccrine carcinoma as a cutaneous manifestation of MEN 2B[J]. J Am Acad Dermatol, 2013, 69(6):e310-e312. [32]Pasini B, Hofstra RM, Yin L, et al. The physical map of the human RET proto-oncogene[J]. Oncogene, 1995, 11(9):1737-1743. [33]Moore SW, Zaahl MG. Multiple endocrine neoplasia syndromes, children, Hirschsprung’s disease and RET[J]. Pediatr Surg Int, 2008, 24(5):521-530. [34]Arighi E, Borrello MG, Sariola H. RET tyrosine kinase signaling in development and cancer[J]. Cyto-kine Growth Factor Rev, 2005, 16(4/5):441-467. [35]Wells SA Jr, Asa SL, Dralle H, et al. Revised Ame-rican Thyroid Association guidelines for the mana-gement of medullary thyroid carcinoma[J]. Thyroid, 2015, 25(6):567-610. [36]Raue F, Rondot S, Schulze E, et al. Clinical utility gene card for: multiple endocrine neoplasia type 2 [J]. Eur J Hum Genet, 2012, 20(1). doi:10.1038/ejhg.2011.142. [37]Yadav K, Bakshi G, Prakash G, et al. Simultaneous bilateral laparoscopic adrenalectomy for pheochro-mocytoma in multiple endocrine neoplasia (MEN) syndrome: case report with review literature[J]. Int J Surg Case Rep, 2014, 5(8):487-490. |
[1] | 江涵,神应强,陈谦明. 毒蕈碱受体通过Yes相关蛋白信号对口腔鳞状细胞癌生物学行为的实验研究[J]. 国际口腔医学杂志, 2022, 49(2): 138-143. |
[2] | 蒋宇磊,夏斌,饶南荃,杨禾丰,许彪. 外泌体在口腔鳞状细胞癌恶性进展及诊疗应用的研究[J]. 国际口腔医学杂志, 2021, 48(6): 711-717. |
[3] | 钱颖,龚佳幸,俞梦飞,刘宇,魏栋,朱子羽,陆科杰,王慧明. 从分子生物学角度对成釉细胞瘤诊断及治疗的考量[J]. 国际口腔医学杂志, 2021, 48(5): 570-578. |
[4] | 王岳,季一鸣,王晓毅,张凌楠,孙乐刚. 人乳头状瘤病毒16相关口咽鳞状细胞癌独特生物学行为及治疗的研究现状[J]. 国际口腔医学杂志, 2021, 48(4): 450-458. |
[5] | 沈洁,何地,刘雁鸣. 下颌下腺良性肿瘤功能性手术的研究进展[J]. 国际口腔医学杂志, 2021, 48(2): 230-237. |
[6] | 卫彬彬,胡慧维,刘玉娟,孙哲,衣玉丽. 放射治疗前使用氨磷汀对头颈部癌症患者口干症等干预效果的Meta分析和GRADE评价[J]. 国际口腔医学杂志, 2020, 47(5): 547-556. |
[7] | 孔利心,任彪,程磊. 环氧合酶2/前列腺素E2通路调控口腔肿瘤机制的研究进展[J]. 国际口腔医学杂志, 2020, 47(4): 431-438. |
[8] | 郝福,宁毅,孙睿,郑晓旭. 口腔鳞状细胞癌中转化因子2β的表达及潜在的临床意义[J]. 国际口腔医学杂志, 2020, 47(2): 159-165. |
[9] | 陈宏丽,杨敬,尹刚,李皓缘,乔燕. 锌指蛋白32在口腔鳞状细胞癌中的表达意义及对口腔鳞状细胞癌干细胞的影响[J]. 国际口腔医学杂志, 2019, 46(6): 631-639. |
[10] | 郝福,孙睿. 头颈部鳞状细胞癌第二原发癌的研究进展[J]. 国际口腔医学杂志, 2019, 46(5): 585-592. |
[11] | 李媛媛,程斌,王韵. 长链非编码RNA lnc-p26090对口腔鳞状细胞癌细胞糖酵解及增殖的影响[J]. 国际口腔医学杂志, 2018, 45(6): 628-634. |
[12] | 王伊婷,何永文. 口腔鳞状细胞癌相关长链非编码RNA调控肿瘤细胞上皮-间充质转化的研究进展[J]. 国际口腔医学杂志, 2018, 45(6): 635-639. |
[13] | 方川,李雅冬. 微小RNA在口腔鳞状细胞癌中的研究进展[J]. 国际口腔医学杂志, 2018, 45(6): 646-651. |
[14] | 余芯乐, 郑军, 徐江, 曾妍. 口腔鳞状细胞癌患者唾液和血清中N-α-乙酰基转移酶10的水平及其临床意义[J]. 国际口腔医学杂志, 2018, 45(4): 391-395. |
[15] | 章茜, 杨旭东. 颌骨囊性病变开窗减压术疗效评价方法的研究进展[J]. 国际口腔医学杂志, 2017, 44(4): 493-496. |
|